Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
Pancreatic cancer is the most common lethal malignancy, with little improvement in patient outcomes over the decades. The development of early detection methods and effective therapeutic strategies are needed to improve the prognosis of patients with this disease. Recent advances in cancer genomics...
Main Authors: | Koji Miyabayashi, Hayato Nakagawa, Kazuhiko Koike |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.682872/full |
Similar Items
-
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
by: Christian Moya Gamboa, et al.
Published: (2021-03-01) -
Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer
by: Tet Woo Lee, et al.
Published: (2020-12-01) -
Novel organoid model in drug screening: Past, present, and future
by: Xialin Nie, et al.
Published: (2021-06-01) -
Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges
by: Erika Durinikova, et al.
Published: (2021-06-01) -
Current Advances in Basic and Translational Research of Cholangiocarcinoma
by: Keisaku Sato, et al.
Published: (2021-07-01)